Get the app!
Back to Trades

Wendel Bruce

DirectorCIK 0001364846

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Wendel Bruce, Director, has filed 3 SEC reports (2025–2026), all concentrated in ImmunityBio, Inc. (IBRX), totaling $820.2K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Jun 10IBRX
ImmunityBio, Inc.
Wendel BruceDirectorAward$475.6K
Dec 16IBRX
ImmunityBio, Inc.
Wendel BruceDirectorOther$0
Dec 16IBRX
ImmunityBio, Inc.
Wendel BruceDirectorAward$344.6K

3 filings